|
Mr. Santel is an experienced senior executive and director with more than 25 years experience in the biotechnology, pharmaceutical and medical device industries. Mr. Santel is the former Chief Executive Officer of CoTherix Inc., a company he led over a period of seven years. Mr. Santel guided CoTherix from being a small private company through several financing rounds and completed an initial public offering on Nasdaq. During that period he also led successful in-licensing efforts for two drugs, fostering one of these through FDA approval. He eventually negotiated the cash acquisition of CoTherix by Actelion in late 2006. Prior to joining CoTherix Mr. Santel filled a range of roles of increasing seniority across the medical device industry at companies including Reflow Inc., Cardiac Pathways Corp. and Medtronic, Inc. Mr. Santel has a MS in Electrical Engineering from the University of Minnesota and a BSE in Biomedical Engineering from Purdue University. | 